Newsroom | 19125 results

PHOENIX--(BUSINESS WIRE)--The Genome Partnership has announced the recipients of the 2026 Next Gen Leadership Awards for the AGBT Agricultural Meeting. These awards recognize outstanding early-career scientists and graduate students whose work is shaping the future of agricultural genomics. Award recipients receive financial support to attend and present their research, with opportunities to engage with leaders in the field and build connections across the genomics community. The AGBT Agricultu...

CHICAGO--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, today announced MuteFree™ AAV, a high-stability AAV vector designed to address ITR instability, a common challenge in gene therapy development. The manuscript describing the technology is now available on bioRxiv. Adeno-associated virus (AAV) remains one of the most widely used gene delivery platforms for therapeutic development. However, inconsistencies in manufacturing and variable thera...

PALO ALTO, Calif. & SÃO PAULO--(BUSINESS WIRE)--Overture Life, the global leader in automated IVF, and Spectrun Bio, a specialist in life sciences commercialization and clinical support across Brazil, today announced a strategic partnership to bring the DaVitri automated IVF laboratory platform to Latin America's largest and most active fertility market. By combining Overture's proven automation technology with Spectrun Bio's deep market knowledge, clinical relationships, and local support infr...

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026. AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Tuesday, May 5, 2026, to discuss its first quarter financial results. Those interested in listening to th...

MENLO PARK, Calif.--(BUSINESS WIRE)--Grace Science, LLC, a biotechnology company founded to develop novel therapies based on the function of NGLY1, announced today that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to GS-100 for the treatment of NGLY1 Deficiency. GS-100 is an investigational AAV9 gene replacement therapy in clinical development to treat NGLY1 Deficiency, an ultra-rare genetic disease with no approved therapy. T...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kincell Bio, a leading contract development and manufacturing organization (CDMO) supporting autologous and allogeneic cell therapy programs, today announced a significant strategic investment to expand and strengthen its Research Triangle Park (RTP), North Carolina facility. The expansion reinforces Kincell Bio's commitment to supporting clients as they advance from late-stage clinical CMC development through commercialization and post-approval li...

MADISON, Wis.--(BUSINESS WIRE)--Promega will distribute NimaGen's IDseek® MPS library prep kits for forensic casework through a new distribution agreement with NimaGen....

NEWTON, Mass.--(BUSINESS WIRE)--4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program...

CAMBRIDGE, England--(BUSINESS WIRE)--ELRIG announces Drug Discovery USA 2026. The inaugural event takes place at Pfizer in Cambridge, MA from 16–17 June and is free to attend....

SAN DIEGO--(BUSINESS WIRE)--U.S. FDA approves FILSPARI (sparsentan) for FSGS...